Pasithea Therapeutics Corp.
KTTA
Revenue
240.71k
▲22.10k▲10.11%
3 Months ChangeAssets
17.66M
▼-4.74M▼-21.17%
3 Months ChangeLiabilities
1.49M
▼-1.04M▼-41.06%
3 Months ChangeFree Cash Flow
-2.53M
▼-2.53M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-30
Form 8-K
ID: 0001213900-24-083408
2024-09-26
Form 8-K
ID: 0001213900-24-081982
2024-08-13
Form 10-Q
ID: 0001213900-24-068297
2024-06-26
Form 8-K
ID: 0001213900-24-056205
2024-05-14
Form 8-K
ID: 0001213900-24-043036
2024-05-14
Form 10-Q
ID: 0001213900-24-042981
2024-01-18
Form 8-K
ID: 0001213900-24-004520
2024-01-02
Form 8-K
ID: 0001213900-24-000296
2023-12-28
Form 8-K
ID: 0001213900-23-099115
2023-12-19
Form 8-K
ID: 0001213900-23-097013